⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15995645 | 0.97 | ALDH1A1 (0.44) | — | |
| Hydrochloric Acid SCHEMBL1557971 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL28153761 | 0.78 | COMT (0.34) | — | |
| SCHEMBL461974 | 0.76 | — | — | |
| SCHEMBL22557846 | 0.74 | — | — | |
| SCHEMBL18232243 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL16060751 | 0.74 | ALDH1A1 (0.38) | — | |
| SCHEMBL28058994 | 0.73 | — | — | |
| SCHEMBL113911 | 0.72 | — | — | |
| SCHEMBL6972723 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 404 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117209485-A | Pyrimidine skeleton compound with anti-tumor activity and preparation method and application thereof | 四川大学华西医院 | 2023-12-12 | — | — | CN | claimed |
| CN-106674116-A | 4-amino-1,3-dimethyl pyrazol and compound method for pharmaceutical acceptable salt thereof | 苏州汉德创宏生化科技有限公司 | 2017-05-17 | — | — | CN | claimed |
| EP-4741018-A2 | SULPHONAMIDE COMPOUNDS | Anaxis Pharma Pty Ltd (AU) | 2026-05-13 | — | — | EP | disclosed |
| EP-4735114-A1 | SUBSTITUTED THIENO [3,2-B]PYRIDINES AS INHIBITORS OF PROTEIN KINASES | Masarykova Univerzita (CZ) | 2026-05-06 | — | — | EP | disclosed |
| US-12583836-B2 | Sulphonamide compounds | Anaxis Pharma Pty Ltd (AU) | 2026-03-24 | — | — | US | disclosed |
| EP-4168401-B1 | SULPHONAMIDE COMPOUNDS | Anaxis Pharma Pty Ltd (AU) | 2026-01-07 | — | — | EP | disclosed |
| US-20250388585-A1 | PRMT5 INHIBITORS AND USES THEREOF | GILEAD SCIENCES INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250376473-A1 | PRMTS INHIBITOR AND USE THEREOF | CYTOSINLAB THERAPEUTICS CO LTD (CN) | 2025-12-11 | — | — | US | disclosed |
| EP-4656249-A2 | PYRAZOLOPYRIMIDINE DERIVATIVES AS KINASE INHIBITOR | Daewoong Pharmaceutical Co., Ltd. (KR) | 2025-12-03 | — | — | EP | disclosed |
| US-12459925-B2 | Sulphonyl urea derivatives as NLRP3 inflammasome modulators | NodThera Limited (GB) | 2025-11-04 | — | — | US | disclosed |
| US-20250333424-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2025-10-30 | — | — | US | disclosed |
| WO-2007099317-A1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2007-09-07 | — | — | WO | disclosed |
| WO-2007099326-A1 | QUINOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2007-09-07 | — | — | WO | disclosed |
| EP-1789014-A1 | SUBSTANCE FOR DYEING KERATINIC FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-05-30 | — | — | EP | disclosed |
| EP-1771150-A1 | CATIONIC AZO COMPOUNDS AS DIRECT DYES FOR THE COLOURING OF KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-04-11 | — | — | EP | disclosed |
| WO-2006029712-A1 | POLYALKOXYLATED DIAMINOBENZENES FOR USE AS DEVELOPERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-03-23 | — | — | WO | disclosed |
| WO-2006029687-A1 | SUBSTANCE FOR DYEING KERATINIC FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-03-23 | — | — | WO | disclosed |
| WO-2006013036-A1 | CATIONIC AZO COMPOUNDS AS DIRECT DYES FOR THE COLOURING OF KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-02-09 | — | — | WO | disclosed |
| EP-1329160-A2 | 4-ACYLAMINOPYRAZOLE DERIVATIVES | Sankyo Company, Limited (JP) | 2003-07-23 | — | — | EP | disclosed |
| CN-1334718-A | Hair treatment method | NOVOZYMES AS (DK) | 2002-02-06 | — | — | CN | disclosed |